CARBAMAZEPINE AND LITHIUM
Although the combined use of lithium and carbamazepine is beneficial in many patients, mild to severe neurotoxicity is reported to have developed in some, and possibly sinus node dysfunction in others.
Monitor the outcome of concurrent use carefully, but note that signs of toxicity have developed even with lithium levels within the normal range. Risk factors appear to be a history of neurotoxicity with lithium therapies and compromised medical or neurological functioning.
Monitor the outcome of concurrent use carefully, but note that signs of toxicity have developed even with lithium levels within the normal range. Risk factors appear to be a history of neurotoxicity with lithium therapies and compromised medical or neurological functioning.